Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis-induced injury

被引:5
|
作者
Wang, Nan [1 ]
Liang, Yan [1 ]
Ma, Qianqian [1 ]
Mi, Jie [1 ]
Xue, Yong [1 ]
Yang, Yourong [1 ]
Wang, Lan [1 ]
Wu, Xueqiong [1 ,2 ]
机构
[1] Peoples Liberat Army Gen Hosp, TB Prevent & Control Key Lab, Beijing Key Lab New Tech TB Diag & Treatment, Sr Dept TB,Med Ctr PLA Gen Hosp 8, Beijing, Peoples R China
[2] Peoples Liberat Army Gen Hosp, TB Prevent & Control Key Lab, Beijing Key Lab New Tech TB Diag & Treatment, Sr Dept TB,Med Ctr PLA Gen Hosp 8, Beijing 100091, Peoples R China
基金
国家重点研发计划;
关键词
ag85a; b DNA; DNA vaccine; immunotherapy; Mycobacterium tuberculosis; transcriptome; SURFACTANT PROTEIN-A; PULMONARY SURFACTANT; IMMUNE-RESPONSE; CHROMOGRANIN-A; T-CELLS; MICE; ELECTROPORATION; IMMUNOGENICITY; DELIVERY; COMBINATION;
D O I
10.1002/iid3.854
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Our previous research developed a novel tuberculosis (TB) DNA vaccine ag85a/b that showed a significant therapeutic effect on the mouse tuberculosis model by intramuscular injection (IM) and electroporation (EP). However, the action mechanisms between these two vaccine immunization methods remain unclear. In a previous study, 96 Mycobacterium tuberculosis (MTB) H(37)Rv-infected BALB/c mice were treated with phosphate-buffered saline, 10, 50, 100, and 200 mu g ag85a/b DNA vaccine delivered by IM and EP three times at 2-week intervals, respectively. In this study, peripheral blood mononuclear cells (PBMCs) from three mice in each group were isolated to extract total RNA. The gene expression profiles were analyzed using gene microarray technology to obtain differentially expressed (DE) genes. Finally, DE genes were validated by real-time reverse transcription-quantitive polymerase chain reaction and the GEO database. After MTB infection, most of the upregulated DE genes were related to the digestion and absorption of nutrients or neuroendocrine (such as Iapp, Scg2, Chga, Amy2a5), and most of the downregulated DE genes were related to cellular structural and functional proteins, especially the structure and function proteins of the alveolar epithelial cell (such as Sftpc, Sftpd, Pdpn). Most of the abnormally upregulated or downregulated DE genes in the TB model group were recovered in the 100 and 200 mu g ag85a/b DNA IM groups and four DNA EP groups. The pancreatic secretion pathway downregulated and the Rap1 signal pathway upregulated had particularly significant changes during the immunotherapy of the ag85a/b DNA vaccine on the mouse TB model. The action targets and mechanisms of IM and EP are highly consistent. Tuberculosis infection causes rapid catabolism and slow anabolism in mice. For the first time, we found that the effective dose of the ag85a/b DNA vaccine immunized whether by IM or EP could significantly up-regulate immune-related pathways and recover the metabolic disorder and the injury caused by MTB.
引用
收藏
页数:27
相关论文
共 50 条
  • [1] Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis
    Liang, Yan
    Wu, Xueqiong
    Zhang, Junxian
    Xiao, Li
    Yang, Yourong
    Bai, Xuejuan
    Yu, Qi
    Li, Zhongming
    Bi, Lan
    Li, Ning
    Wu, Xiaoli
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2012, 66 (03): : 419 - 426
  • [2] Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation
    Liang, Yan
    Cui, Lei
    Xiao, Li
    Liu, Xiao
    Yang, Yourong
    Ling, Yanbo
    Wang, Tong
    Wang, Lan
    Wang, Jie
    Wu, Xueqiong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A
    Sugawara, I.
    Udagawa, T.
    Taniyama, T.
    TUBERCULOSIS, 2007, 87 (02) : 94 - 101
  • [4] Differential B-Cell responses are induced by Mycobacterium tuberculosis Ag85A synthetic peptides in two populations from Venezuela
    Fernandez de Larrea, C.
    Giampietro, F.
    Dinis, J.
    Patarroyo, M. A.
    Vanegas, M.
    Reyes, C.
    Araujo, Z.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E317 - E318
  • [5] Construction of a DNA vaccine based on the Mycobacterium tuberculosis Ag85A/MPT64 fusion gene and evaluation of its immunogenicity
    Bao, Hong
    Yu, Ting
    Jin, Yufen
    Teng, Chunyan
    Liu, Ximing
    Li, Yanlei
    MOLECULAR MEDICINE REPORTS, 2012, 6 (06) : 1375 - 1378
  • [6] The mechanisms of Ag85A DNA vaccine activates RNA sensors through new signal transduction
    Zhai, Jingbo
    Wang, Qiubo
    Gao, Yunfeng
    Zhang, Ran
    Li, Shengjun
    Wei, Bing
    You, Yong
    Sun, Xun
    Lu, Changlong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 59 : 1 - 11
  • [7] DNA VACCINE CONSTRUCTION OF MYCOBACTERIUM TUBERCULOSIS AG85A/MPT-64 FUSION GENE AND THE APPLICATION OF ELISPOT ASSAY FOR IMMUNOGENICITY ANALYSIS
    Hong, B.
    Jin, Y. F.
    Li, Y. L.
    Ting, Y.
    RESPIROLOGY, 2011, 16 : 18 - 18
  • [8] Immunogenicity of a DNA Vaccine Encoding Ag85a-Tb10.4 Antigens from Mycobacterium Tuberculosis
    Meshkat, Zahra
    Teimourpour, Amir
    Rashidian, Samira
    Arzanlou, Mohsen
    Teimourpour, Roghayeh
    IRANIAN JOURNAL OF IMMUNOLOGY, 2016, 13 (04) : 289 - 295
  • [9] Mapping of murine Th1 helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis
    D'Souza, S
    Rosseels, V
    Romano, A
    Tanghe, A
    Denis, O
    Jurion, P
    Castiglione, N
    Vanonckelen, A
    Palfliet, K
    Huygen, K
    INFECTION AND IMMUNITY, 2003, 71 (01) : 483 - 493
  • [10] Therapeutic effects of pJW Ag 85B DNA vaccine during chemotherapy in mice infected with Mycobacterium tuberculosis
    Kim, Y. S.
    Kim, M. H.
    Lee, S. E.
    Cho, W. H.
    Seol, H. Y.
    Kim, J. E.
    Kim, K. U.
    Cheon, D. S.
    Park, H. K.
    Lee, M. K.
    Park, S. K.
    Choi, I. S.
    Lee, J. H.
    Kornfeld, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181